AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference

  AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference

Morgan Stanley Global Healthcare Conference 2013

Business Wire

CAMBRIDGE, Mass. -- September 4, 2013

AVEO Oncology (NASDAQ: AVEO) today announced that Tuan Ha-Ngoc, chief
executive officer, is scheduled to present at the Morgan Stanley Global
Healthcare Conference on Wednesday, September 11, 2013 at 12:55 p.m. (ET) in
New York City.

A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com. A
replay of the webcast will be archived on the AVEO website for two weeks
following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to
discovering, developing and commercializing targeted therapies to impact
patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the
company unique insights into cancer biology and is being leveraged in the
discovery and clinical development of its cancer therapeutics. For more
information, please visit the company’s website at www.aveooncology.com.

Contact:

AVEO Oncology
David Johnston, 617-299-5810
or
Pure Communications
Dan Budwick, 336-774-8666